Zannes Maria 4
4 · bioAffinity Technologies, Inc. · Filed Apr 24, 2024
Insider Transaction Report
Form 4
Zannes Maria
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Common Stock
2024-04-08$1.16/sh+64,848$75,224→ 229,506 total - Tax Payment
Common Stock
2024-04-08$2.65/sh−28,264$74,900→ 201,242 total - Exercise/Conversion
Stock Option (right to buy)
2024-04-08−64,848→ 0 totalExercise: $1.16Exp: 2024-04-28→ Common Stock (64,848 underlying)
Footnotes (2)
- [F1]Represents shares withheld to cover the exercise price of the options exercised.
- [F2]This option vested in 7 equal monthly installments beginning on April 28, 2014.